Why is Remus Pharma. falling/rising?

As of 03-Sep, Remus Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 880.60, which reflects a decrease of 24.25 or 2.68%. The stock has underperformed its sector by 3.92% today and is trading below its moving averages across all time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 45.78% compared to the 5-day average. Over the past year, the stock has seen a substantial decline of 33.03%, while year-to-date it has decreased by 29.48%. Unfortunately, there is no information available regarding positive or negative factors that could influence the stock's recent movement.
In the broader market context, the stock's performance over the past week shows a decline of 5.17%, while the benchmark Sensex has remained relatively flat with a change of +0.01%. This indicates that Remus Pharmaceuticals is not only underperforming against its sector but also lagging behind the overall market. The year-to-date performance further highlights this trend, as the stock has dropped significantly while the Sensex has gained 4.53%. This disparity suggests that investor sentiment towards Remus Pharmaceuticals is weak compared to the broader market, contributing to the ongoing decline in its stock price.